Woodline Partners’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Woodline Partners’s Portfolio VECT Stock Details VECT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-33,827	Closed	-$571K	–	807
2023 Q2	$571K	Buy	+33,827	New	+$445K	0.01%	531
2022 Q1	–	Sell	-86,888	Closed	-$427K	–	868
2021 Q4	$427K	Hold	86,888	–	–	0.01%	561
2021 Q3	$671K	Buy	86,888 +292	+0.3%	+$2.5K	0.01%	535
2021 Q2	$1.01M	Buy	+86,596	New	+$1.31M	0.02%	427

Other funds holding VECT

RCM

Regency Capital Management Honolulu, Hawaii $224M AUM 26.03% 1-Year Est. Return

SOW

State of Wyoming Cheyenne, Wyoming $844M AUM 37.96% 1-Year Est. Return

Woodline Partners's VECT Position: Q3 2023 in Review

Woodline Partners sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q3 2023, closing a stake of 33,827 shares — an estimated $571K sold.

Woodline Partners first reported a position in VECT in Q2 2021 and held it in 4 quarters. The position peaked at $1.01M in Q2 2021. 2 funds tracked by Wall St. Rank hold VECT as of Q3 2023.

Woodline Partners reported no remaining VectivBio Holding AG Ordinary Shares position as of Q3 2023 after selling out during the quarter.
Woodline Partners sold 33,827 VectivBio Holding AG Ordinary Shares shares in Q3 2023, an estimated $571K.
Woodline Partners first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2021 and held it in 4 quarters.
Woodline Partners's VectivBio Holding AG Ordinary Shares position peaked at $1.01M in Q2 2021.
2 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q3 2023.

Based on Woodline Partners's 13F filing for Q3 2023, filed 14 Nov 2023.